Company watch: PE-backed Intas Pharma enjoying a healthy dose of growth

Premium

It was in 1996 that Intas Pharmaceuticals Ltd first attracted a private equity investor. Twenty-one years later, PE firms’ interest in the drugmaker hasn’t dampened much.Earlier this month, US-based investment firm Capital International acquired a 3% stake in the Ahmedabad-based company from homegrown PE firm ChrysCapital for Rs 690 crore ......